Skip to main content

Sanofi shares down despite $13 billion Regeneron payday

Shares in Sanofi fell on Tuesday despite the French drugmaker's impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.